These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 11353617)

  • 1. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.
    Doern GV; Heilmann KP; Huynh HK; Rhomberg PR; Coffman SL; Brueggemann AB
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1721-9. PubMed ID: 11353617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
    Zhanel GG; Palatnick L; Nichol KA; Bellyou T; Low DE; Hoban DJ
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1867-74. PubMed ID: 12760860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.
    Low DE; de Azavedo J; Weiss K; Mazzulli T; Kuhn M; Church D; Forward K; Zhanel G; Simor A; McGeer A
    Antimicrob Agents Chemother; 2002 May; 46(5):1295-301. PubMed ID: 11959559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
    Hsueh PR; Teng LJ; Lee CM; Huang WK; Wu TL; Wan JH; Yang D; Shyr JM; Chuang YC; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Leu HS; Liu CY; Luh KT;
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
    Doern GV; Brueggemann A; Holley HP; Rauch AM
    Antimicrob Agents Chemother; 1996 May; 40(5):1208-13. PubMed ID: 8723468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
    Kays MB; Lisek CR; Denys GA
    Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.
    Hsueh PR; Teng LJ; Wu TL; Yang D; Huang WK; Shyr JM; Chuang YC; Wan JH; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Lee CM; Leu HS; Liu CY; Luh KT;
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2145-51. PubMed ID: 12821460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections.
    Penland RL; Wilhelmus KR
    Cornea; 1998 Mar; 17(2):135-40. PubMed ID: 9520187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial resistance of Streptococcus pneumoniae, 2003-2009].
    Năstase E; Dorneanu O; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):536-41. PubMed ID: 21870753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?
    Doern GV; Richter SS; Miller A; Miller N; Rice C; Heilmann K; Beekmann S
    Clin Infect Dis; 2005 Jul; 41(2):139-48. PubMed ID: 15983908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.
    Thornsberry C; Ogilvie PT; Holley HP; Sahm DF
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2612-23. PubMed ID: 10543737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.
    Brueggemann AB; Coffman SL; Rhomberg P; Huynh H; Almer L; Nilius A; Flamm R; Doern GV
    Antimicrob Agents Chemother; 2002 Mar; 46(3):680-8. PubMed ID: 11850248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
    Felmingham D; Reinert RR; Hirakata Y; Rodloff A
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():25-37. PubMed ID: 12239226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.
    Nagai K; Appelbaum PC; Davies TA; Kelly LM; Hoellman DB; Andrasevic AT; Drukalska L; Hryniewicz W; Jacobs MR; Kolman J; Miciuleviciene J; Pana M; Setchanova L; Thege MK; Hupkova H; Trupl J; Urbaskova P
    Antimicrob Agents Chemother; 2002 Feb; 46(2):371-7. PubMed ID: 11796344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
    Morosini MI; Cantón R; Loza E; Negri MC; Galán JC; Almaraz F; Baquero F
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2427-31. PubMed ID: 11502509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.
    Lemmen S; Al-Lahham A; Lütticken R; Reinert RR
    Chemotherapy; 2001; 47(2):104-9. PubMed ID: 11173811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative In vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America. The Gemifloxacin Surveillance Study Research Group.
    Hoban DJ; Bouchillon SK; Karlowsky JA; Johnson JL; Butler DL; Miller LA; Poupard JA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3008-11. PubMed ID: 11036014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.